- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-06-01-2019
Pharmaceutical Executive
Pharm Exec's Top 50 Companies 2019
July 12, 2019
Features
39
6
Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market.
The Argument for External Comparator Adoption
June 28, 2019
Columns
39
6
Its use, new data shows, could boost the economic benefit profile of more “common” drugs-and better inform HTA and payer decision-making.
Pharma Medical Affairs: A Blueprint for Future
June 24, 2019
Features
39
6
Changing customer preferences and a growing need for specialized knowledge are challenging the traditional scope of the medical affairs function. Learn about six ways pharma MA departments can drive more collaborative relationships with caregivers.
'Vision’ Quest: Leading Through Change
June 21, 2019
Features
39
6
Exploring the critical go-to strategies for biopharma C-suite executives in navigating organizational disruption and the impact of global change and volatility on their employees and business.
Pharm Exec 50 Hints to Rest of ’19
June 13, 2019
From the Editor
39
6
Our latest rankings and report of the top 50 biopharma companies provides a nice springboard to the coverage we have in store for you in the year's second half.
Predicting the Future of European Health Policy
June 11, 2019
Columns
39
6
With a new Commission looming, here’s who’s vying for the top spot in shaping EU strategy, including key questions in pharma.
A Critical Juncture for Antibiotic R&D
June 11, 2019
Columns
39
6
With little momentum in developing new new antibiotics to fight antimicrobial resistance, the time is now to emphasize "push" and "pull" incentives and demonstrate how innovation in this area will lead to patient benefit and economic reward.
New Strategies Sought to Pay for Costly Cures
June 10, 2019
Columns
39
6
Cell and gene therapies in crosshairs of pricing focus, prompting stepped-up proposals on ways to finance these products.
Pharmaceutical Executive, June 2019 Issue (PDF)
June 01, 2019
Issue PDF
39
6
Click the title above to open the Pharmaceutical Executive June 2019 issue in an interactive PDF format.
Site Payments: Drilling in on Forecast, Budget Issues
June 01, 2019
Columns
39
6
Repurposing existing technology to alleviate traditional ‘pain points’ in ensuring clinical investigator payments transparency
Building the Startup Dream Team
June 01, 2019
Columns
39
6
Key staffing strategies for emerging biopharma entrepreneurs in attracting the talent to bring their visions and ideas to life.
Country Report: France
June 01, 2019
Special Sponsored Section
39
6
After several years of losing pace to many of its European peers when it comes to pharma production and R&D, France’s life sciences market, sparked by a renewed spirit of reform, is now squarely back on the radar of the international investor community.